Divisions & Faculty

Background

• MD Degree: University of Connecticut
• Internship: Purdue University
• Residency: Purdue University
• Fellowship: Boston University/Harvard University

Certifications

• American Board of Pediatrics
• American Board of Psychiatry & Neurology
• Child Neurology

Clinical Interests

• Epilepsy
• Headaches
• Behavioral Distrubances
• Muscular dystrophy
• Neurofibromatosis
• Developmental disorder (autism(
• Tourette's Syndrome
• Sleep disorders

Professional Affiliations

American Academy of Neurology
American Academy of Pediatrics
American Epilepsy Society
American Medical Association
Autism Society of America
Association of Clinical Research Professionals
Child Neurology Society
Duke Medical Alumni Association
Epilepsy Association of Virginia
International Tourette Syndrome Association
Medical Society of Virginia
National Neurofibromatosis Society
National Tuberous Sclerosis Association
Neurology Subsection, American Academy of Pediatrics
Norfolk Academy of Medicine
Tidewater Neurological Society
Tidewater Pediatric Society
Tourette Syndrome Association
University of Connecticut Medical Alumni Association
Virginia Neurological Society, Neuroimaging Committee
Virginia Pediatric Society

Selected Publications

Frank LM: Lamotrigine: An Effective Alternative for Absence Epilepsy in Childhood, Search on Epilepsy,   7(4):16-18, 2000

Frank LM: Treatment of Absence Epilepsy, Search on Epilepsy, 8(2):3-5, 2001

Lewis DW, Frank LM, Toor S: Familial neck-tongue syndrome. Headache, 43(2):132-4, 2003

Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Toor RS, White LW, Lawson L: Children’s ibuprofen   suspension for the treatment of pediatric migraine. Headache, 42(8): 780-6, 2003

Lewis DW, Frank LM, White L: Consultant’s corner: the “breakthrough” seizure. Clin Ped Emerg Med, 4:221-225, 2003

Holmes GL, Frank LM, Sheth RD, Wooten JD, Vuong A, Kerla S, Hammer AE, Messenheimer J; Lamotrigine monotherapy for newly diagnosed typical  absence seizures in children. Epilepsy Res Sep 6, 2008 (EPub)

Shinnar S, Hesdorfer DC, Nordli DR Jr, Pellock JM, Lewis DV, Moshe SL, Epstein LG, Mamarou A, Bagiiella E, FEBSTAT Study Team;  Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology, 3:170-6, 2008

Newcom JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D, Atamoxetine/Methylphenidate Comparative Study Group: Atamoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165(6):721-30, 2008

Frank LM: Absence seizures, a chapter in Pediatric Epilepsy Case Studies: From Infancy and Childhood through Adolescence, Chapman K, and Kong MR eds.: CRC Press,l Taylor and Francis Group, Boca Ratan, FL 2008

RECENT RESEARCH AND TRAINING GRANTS AND CONTRACTS:
PRINCIPAL INVESTIGATOR

Harcoseride- Protocol SP754, Schwarz Pharmaceuticals, A Multicenter, Double-Blind,   Randomized, Placebo Controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600 mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization. Principal Investigator:  LM Frank; Sub Investigators: DL Lewis, SS Toor, LE White, RS Northam.

Harcoseride- Protocol SP756, Schwarz Pharmaceuticals, An Open Label Extension Trial to Determine Safety and Efficacy of Long-Term Oral SPM 927 in Patients with Partial Seizures,  Principal
Investigator: LM Frank; Sub Investigators: DL Lewis, SS Toor, LE White, RS Northam.

Clobazam-OV-1002, Ovation Pharmaceuticals, Safety and Efficacy of Clobazam in Subjects with  Lennox-Gastaut Syndrome.  Principal Investigator; LM Frank; Sub-Investigators:  DW Lewis,
SS Toor, RS Northam, LE White

Clobazam-OV-1004, Ovation Pharmaceuticals, Safety and Effectiveness of Open-Label Clobazam  In Subjects with Lennox-Gastaut Syndrome.  Principal Investigator:  LM Frank;                              Sub-Investigators